Belmont, MA, United States of America

Meena

USPTO Granted Patents = 12 

Average Co-Inventor Count = 5.1

ph-index = 11

Forward Citations = 355(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Meena from Belmont, MA**

Introduction

Inventor Meena, based in Belmont, Massachusetts, has made noteworthy contributions to the field of oligonucleotide research with a remarkable portfolio of 11 patents. His innovative work focuses on the complex area of chirally controlled oligonucleotides, which have significant implications in genetic research and therapeutics.

Latest Patents

Meena’s latest patents demonstrate groundbreaking advancements in chirality within the field:

1. **Chiral Control**: This invention relates to chirally controlled oligonucleotides and their compositions. It addresses previous methodological challenges in creating fully chirally controlled compositions of oligonucleotides, particularly those comprising diverse types. The invention includes methods of producing chirally controlled oligonucleotides and compositions, enhancing the reliability of nucleic acid studies.

2. **Chiral Design**: This second patent focuses on specific designs of chirally controlled oligonucleotides. It outlines compositions that show distinct cleavage patterns when interacting with nucleic acid polymers, offering functionalities not available in traditional oligonucleotide compositions. This innovation may lead to improved precision in genetic manipulation and therapeutics.

Career Highlights

Meena is associated with Wave Life Sciences Ltd., a leading company at the forefront of genetic research, where he applies his expertise in oligonucleotide design. His work has not only propelled the company towards significant breakthroughs but has also contributed to the broader scientific community's understanding of chirality in biochemistry.

Collaborations

Throughout his career, Meena has worked alongside notable colleagues such as Gregory Lawrence Verdine and Naoki Iwamoto. These collaborations have fostered a rich exchange of ideas and techniques, further enhancing the innovative capabilities of their team and advancing their collective research goals.

Conclusion

With a total of 11 patents and a focus on chirality in oligonucleotides, Meena stands out as a prominent inventor in his field. His latest innovations are paving the way for future research and applications in genetics, making significant strides in biochemistry and molecular biology. Through his career at Wave Life Sciences Ltd. and collaborative efforts, Meena is poised to continue making impactful contributions to science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…